相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold
Kento Fujiwara et al.
CELLS (2020)
Impact of scFv structure in chimeric antigen receptor on receptor expression efficiency and antigen recognition properties
Kento Fujiwara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Immunogenicity of Chimeric Antigen Receptor T-Cell Therapeutics
Boris Gorovits et al.
BIODRUGS (2019)
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Stefan Stoiber et al.
CELLS (2019)
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
Breelyn A. Wilky et al.
LANCET ONCOLOGY (2019)
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers
Andrew R. Haas et al.
MOLECULAR THERAPY (2019)
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
Indu Ramachandran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
Nikolaos Zacharakis et al.
NATURE MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
Sriram Vaidyanathan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study
J. Tabernero et al.
ANNALS OF ONCOLOGY (2018)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Fully human CD19-specific chimeric antigen receptors for T-cell therapy
D. Sommermeyer et al.
LEUKEMIA (2017)
Effects of Chemically Modified Messenger RNA on Protein Expression
Bin Li et al.
BIOCONJUGATE CHEMISTRY (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
Jin Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research
Kanako Inoo et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype
Jamie Lim et al.
CLINICAL CANCER RESEARCH (2015)
Understanding the Influence of Codon Translation Rates on Cotranslational Protein Folding
Edward P. O'Brien et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma
Toru Wakamatsu et al.
CANCER SCIENCE (2014)
Potential for immunotherapy in soft tissue sarcoma
William W. Tseng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody
Mai Yoshikawa et al.
BLOOD (2013)
Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy
N. Kanagawa et al.
CANCER GENE THERAPY (2013)
Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma: An Immunohistochemical Study of 262 Vascular Endothelial and 1640 Nonvascular Tumors
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
Antonio Di Stasi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Advances in sarcoma genomics and new therapeutic targets
Barry S. Taylor et al.
NATURE REVIEWS CANCER (2011)
分享论文
